Gulf Coast TX
Gilead's pill succeeds in mid-stage bowel disease trial
Oct 19 (Reuters) -- Gilead Sciences said on Monday its experimental once-daily pill reduced symptoms of a chronic bowel illness in more patients than placebo in a mid-stage trial.…
